Scholarlink

Background <p>Medium chain acyl CoA dehydrogenase deficiency (MCADD) is a rare, autosomal recessive disorder of fatty acid β-oxidation, which is typically diagnosed via newborn screening in the United States. Nutrition management during times of wellness and emergency care during times of illness are necessary to optimize outcomes. While guidelines for care have been published, there is variability in management between clinics.</p> Body <p>The <i>2023 MCADD Patient and Family Education Summit with Providers</i> was a global virtual summit of parents/carers of children with MCADD, adult patients, and healthcare providers to explore current trends and to identify unmet needs related to MCADD management. The summit included presentations by specialists and open discussions between patients, parents/carers and providers. We identified areas in which patients/carers and providers were in agreement (e.g., provision of emergency letters), and areas where there appeared to be discordance (e.g., provision of sick day protocols and use of home glucose monitors).</p> Conclusion <p>The summit provided an innovative model for education and research, effectively engaging a global audience around patient-centered priorities and to advance research. Creating more opportunities for such educational and discussion forums could benefit both attendees and those involved in MCADD or other rare genetic disorders research, potentially improving patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

2023 MCADD patient and family education summit with providers: meeting highlights, congruences and contradictions

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月9日

查看全文
  • Rani H. Singh,
  • Saran R. Gurung,
  • Aileen Kenneson,
  • Hans C. Andersson

摘要

Background

Medium chain acyl CoA dehydrogenase deficiency (MCADD) is a rare, autosomal recessive disorder of fatty acid β-oxidation, which is typically diagnosed via newborn screening in the United States. Nutrition management during times of wellness and emergency care during times of illness are necessary to optimize outcomes. While guidelines for care have been published, there is variability in management between clinics.

Body

The 2023 MCADD Patient and Family Education Summit with Providers was a global virtual summit of parents/carers of children with MCADD, adult patients, and healthcare providers to explore current trends and to identify unmet needs related to MCADD management. The summit included presentations by specialists and open discussions between patients, parents/carers and providers. We identified areas in which patients/carers and providers were in agreement (e.g., provision of emergency letters), and areas where there appeared to be discordance (e.g., provision of sick day protocols and use of home glucose monitors).

Conclusion

The summit provided an innovative model for education and research, effectively engaging a global audience around patient-centered priorities and to advance research. Creating more opportunities for such educational and discussion forums could benefit both attendees and those involved in MCADD or other rare genetic disorders research, potentially improving patient outcomes.